Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

yep, COVID is OVER for AGN. "Results were not 'Stellar' and moving to a Phase 3 against Vaccines and ZBP$ would have been dumb.

The data remains but has not been made public. Just claims of 'trends' for "low O2" and for "IL-6 reduction". Speculative situation.

Ifenprodil HAS made it to Human testing and completed a Phase 2 CT.

The INDs are supported by completed studies for the NEW proposed 'Indications'.
Chronic Cough thru the recent Clinical Trials done by AGN.
The Tumor/Cancer treatment research was done at Dartmoth. THEN licensed.

Ifenprodil has already passed a DSMB Safety review for a Phase 2 CT.

With the refund cash in the bank there should be no immediate need for more cash until some results for the applications are seen.

Any application to up-list will take time.

IND approval timeline is hard to figure. AGN is requesting three different pre-IND meetings.

I am betting against your scenario and that there wont be a R/S before a PPS recovery.** Nasdaq 2022...GLTA...

**if a R/S is needed at all!!!


https://www.drugs.com/fda-approval-process.html#:~:text=Priority%20Review%3A%20During%20Priority%20Review%2C%20the%20FDA%20takes,the%20treatment%2C%20diagnosis%2C%20or%20prevention%20of%20serious%20conditions.